ホーム › 悪性黒色腫 › フロリダ州 › Jacksonville
Jacksonville、FLにおける悪性黒色腫の臨床試験
Jacksonvilleとその周辺地域（約30マイル以内）の拠点で、悪性黒色腫に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
被験者募集中第3相
- Mayo Clinic Florida, Jacksonville
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
被験者募集中第2相
- Nemours Children's Clinic-Jacksonville, Jacksonville
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
被験者募集中第1相
- Mayo Clinic - Florida, Jacksonville
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Nemours Children's Clinic-Jacksonville, Jacksonville
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
被験者募集中第1/2相
- Mayo Clinic in Florida, Jacksonville
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
被験者募集中第2相
- Baptist - MD Anderson Cancer Center, Jacksonville
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
被験者募集中第1/2相
- Mayo Clinic, Jacksonville
Neoadjuvant Darovasertib in Primary Uveal Melanoma
被験者募集中第3相
- Mayo Clinic Jacksonville, Jacksonville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
被験者募集中第2/3相
- Mayo Clinic - Jacksonville FL, Jacksonville
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
被験者募集中第3相
- Mayo Clinic Florida, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Jacksonville
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Baptist MD Anderson Cancer Center, Jacksonville
- Mayo Clinic in Florida, Jacksonville
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
被験者募集中第1/2相
- Mayo Clinic in Florida, Jacksonville
他の都市における悪性黒色腫の試験
- Houston, TX59件の研究
- New York City, NY38件の研究
- Los Angeles, CA34件の研究
- Nashville, TN33件の研究
- Pittsburgh, PA31件の研究
- Boston, MA26件の研究
- Philadelphia, PA23件の研究
- San Francisco, CA22件の研究
- Durham, NC21件の研究
- Atlanta, GA21件の研究
- St. Louis, MO21件の研究
- Salt Lake City, UT21件の研究
Jacksonvilleにおける他の研究
- 乳がん40件の研究
- 非小細胞肺癌39件の研究
- がん（全種類）29件の研究
- 転移性癌28件の研究
- 大腸癌27件の研究
- 前立腺がん26件の研究
- 肥満症25件の研究
- 心不全21件の研究
- 膵臓がん20件の研究
- 過体重19件の研究
- 多発性骨髄腫18件の研究
- 肺がん17件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。